Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rare CNS Primary Tumors”

27 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 27 results

Not applicableEnrolling By InvitationNCT03836300
What this trial is testing

Parent and Infant Inter(X)Action Intervention (PIXI)

Who this might be right for
Fragile X SyndromeAngelman SyndromePrader-Willi Syndrome+11 more
RTI International 120
Not applicableStudy completedNCT05199402
What this trial is testing

Clinical Trial Data Set Re-use With Statistical Methodologies Tailored for Clinical Trials in Rare Diseases

Who this might be right for
Tuberous SclerosisEpilepsy
Imagine Institute 10
Not applicableLooking for participantsNCT04194619
What this trial is testing

Pregnancy in Women With Rare Multisystemic Vascular Diseases: COGRare5 Study

Who this might be right for
Vascular AnomalyOsler Rendu DiseaseMarfan Syndrome or Related+3 more
Hospices Civils de Lyon 400
Early research (Phase 1)Looking for participantsNCT04541082
What this trial is testing

Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms

Who this might be right for
Central Nervous System NeoplasmsGlioblastomaGliosarcoma, Adult+20 more
Jazz Pharmaceuticals 102
Not applicableUnknownNCT05347511
What this trial is testing

Study of the Pronostic Impact of Immunohistochemical, Histological and Radiological Factors in Patients With Primary Central Nervous System Lymphoma.

Who this might be right for
Rare Disease With Poor Outcome
Central Hospital, Nancy, France 94
Not applicableLooking for participantsNCT06065852
What this trial is testing

National Registry of Rare Kidney Diseases

Who this might be right for
Adenine Phosphoribosyltransferase DeficiencyAH AmyloidosisAHL Amyloidosis+81 more
UK Kidney Association 35,000
Not applicableStudy completedNCT02365922
What this trial is testing

Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL)

Who this might be right for
FTLDProgressive Supranuclear Palsy (PSP)Frontotemporal Dementia (FTD)+9 more
University of California, San Francisco 1,489
Not applicableStudy completedNCT03251989
What this trial is testing

Rare CNS Tumors Outcomes &Risk

Who this might be right for
High Grade MeningiomaEpendymomaMedulloblastoma+2 more
National Cancer Institute (NCI) 326
Not applicableLooking for participantsNCT03416114
What this trial is testing

RegistRare: a Retro-prospective Registry of Rare Primary Headaches in Italian Tertiary Headache Centres

Who this might be right for
Headache Disorders
Silvia Benemei 3,000
Early research (Phase 1)Looking for participantsNCT02897063
What this trial is testing

Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure

Who this might be right for
Autonomic FailurePure Autonomic FailureMultiple System Atrophy+2 more
Vanderbilt University Medical Center 34
Not applicableUnknownNCT02006134
What this trial is testing

Pediatric Vasculitis Initiative

Who this might be right for
Wegeners Granulomatosis (Granulomatosis With Polyangiitis)Microscopic PolyangiitisEosinophilic Granulomatosis With Polyangiitis+4 more
University of British Columbia 1,600
Not applicableStudy completedNCT01000753
What this trial is testing

Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma

Who this might be right for
Adult Immunoblastic LymphomaCentral Nervous System Non-Hodgkin LymphomaChildhood Immunoblastic Lymphoma+10 more
Children's Oncology Group 174
Early research (Phase 1)Active Not RecruitingNCT02726711
What this trial is testing

Reduction in Splanchnic Capacitance Contributes to Sympathetically Dependent Hypertension in Autonomic

Who this might be right for
Multiple System AtrophyOrthostatic HypotensionSupine Hypertension
Vanderbilt University 2
Not applicableStudy completedNCT05161494
What this trial is testing

Gait in Rare Diseases

Who this might be right for
Tuberous SclerosisSTXBP1 Encephalopathy With Epilepsy
Universiteit Antwerpen 41
Not applicableLooking for participantsNCT07575347
What this trial is testing

Periodontal Disease in Rare Renal Disorders (PERIO-RA-RE)

Who this might be right for
Periodontal DiseasePeriodontitisCKD+6 more
Stefan Lujinschi 100
Not applicableActive Not RecruitingNCT03655223
What this trial is testing

Early Check: Expanded Screening in Newborns

Who this might be right for
Spinal Muscular AtrophyFragile X SyndromeFragile X - Premutation+182 more
RTI International 30,000
Not applicableStudy completedNCT06714370
What this trial is testing

Real-World Evidence of Effectiveness and Safety of Tirabrutinib in Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma in Taiwan: A Nationwide Study

Who this might be right for
Primary Central Nervous System Lymphoma (PCNSL)
Ono Pharmaceutical Co., Ltd. 24
Testing effectiveness (Phase 2)Looking for participantsNCT06804655
What this trial is testing

Pharmacoscopy for Patients With Refractory Primary Brain Tumors

Who this might be right for
Brain (Nervous System) CancersGlioblastomaGlioma+5 more
University of Zurich 40
Testing effectiveness (Phase 2)UnknownNCT00004659
What this trial is testing

Phase II Randomized Study of Stereotactic Radiosurgery Plus Fractionated Whole-Brain Radiotherapy Vs Fractionated Whole-Brain Radiotherapy Alone for Multiple Primary or Metastatic Brain Tumors

Who this might be right for
Brain Neoplasms
National Institute of Neurological Disorders and Stroke (NINDS) 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT02867592
What this trial is testing

Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors

Who this might be right for
Adrenal Cortical CarcinomaAlveolar Soft Part SarcomaCentral Nervous System Neoplasm+41 more
National Cancer Institute (NCI) 109
Next Page